Carlos M.
- Country
- Spain
- Department
- Endocrinology and metabolism
Research Overview
Specializations
Metabolic and Endocrine Disorders
Investigator Carlos Morillas concentrates on disorders of metabolism and endocrine regulation, including Obesity, type 2 diabetes, and broader Metabolic syndrome manifestations.
- Obesity management
- type 2 diabetes therapy optimization
- Metabolic syndrome intervention strategies
- Hormonal dysregulation
Clinical activities are performed at Hospital Universitario Dr Peset Aleixandre in Valencia.
Renal and Glomerular Diseases
Research emphasizes glomerular pathologies such as IgA nephropathy, Lupus nephritis, and C3 glomerulopathy, alongside progressive Chronic kidney disease.
- IgA nephropathy therapeutic trials
- Lupus nephritis treatment pathways
- C3 glomerulopathy disease-modifying approaches
- Chronic kidney disease progression mitigation
Key objectives include proteinuria reduction and preservation of renal function.
Hematologic Malignancies
Focus is placed on plasma‑cell disorders and lymphoid neoplasms, notably Multiple myeloma, Acute myeloid leukemia, and various lymphomas.
- Multiple myeloma novel regimens
- Acute myeloid leukemia therapeutic strategies
- Follicular lymphoma targeted therapies
- Diffuse large B‑cell lymphoma clinical evaluation
Studies address both newly diagnosed and relapsed/refractory disease settings.
Neurodegenerative and Cognitive Disorders
Investigator Morillas engages in early‑stage neurodegeneration research, covering Alzheimer’s disease, Mild cognitive impairment, and Early Parkinson’s disease with attention to neuroinflammatory mechanisms.
- Alzheimer’s disease disease‑modifying trials
- Mild cognitive impairment prevention studies
- Early Parkinson’s disease intervention research
- Neuroinflammation
Efforts incorporate biomarker integration to refine therapeutic targets.
Autoimmune and Systemic Connective‑Tissue Diseases
Active investigation of systemic autoimmunity includes Systemic lupus erythematosus, Systemic sclerosis, skin blistering disease Bullous pemphigoid, and inflammatory bowel disease Ulcerative colitis.
- Systemic lupus erythematosus activity modulation
- Systemic sclerosis organ‑specific therapy
- Bullous pemphigoid treatment innovation
- Ulcerative colitis therapeutic advancement
Projects aim to improve organ outcomes and patient quality of life.
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.